DNA Link Inc
JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing. The company also provides microarray… Read more
DNA Link Inc (127120) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.044x
Based on the latest financial reports, DNA Link Inc (127120) has a cash flow conversion efficiency ratio of -0.044x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.05 Billion) by net assets (₩46.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DNA Link Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how DNA Link Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DNA Link Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DNA Link Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shaily Engineering Plastics Limited
NSE:SHAILY
|
0.155x |
|
Henan Thinker Automation
SHG:603508
|
0.029x |
|
INVEX Controladora S.A.B. de C.V
MX:INVEXA
|
0.059x |
|
KATITAS CO., Ltd.
PINK:KTITF
|
N/A |
|
Winner Information Technology Co Inc
SHE:300609
|
-0.010x |
|
Grupo Posadas S.A.B. de C.V
MX:POSADASA
|
0.007x |
|
Scientech Corp
TW:3583
|
0.055x |
|
Fuxin Dare Automotive Parts Co Ltd
SHE:300473
|
0.063x |
Annual Cash Flow Conversion Efficiency for DNA Link Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of DNA Link Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩25.03 Billion | ₩-6.78 Billion | -0.271x | -41.54% |
| 2023-12-31 | ₩26.28 Billion | ₩-5.03 Billion | -0.191x | -686.44% |
| 2022-12-31 | ₩27.89 Billion | ₩910.27 Million | 0.033x | +116.64% |
| 2021-12-31 | ₩32.77 Billion | ₩-6.43 Billion | -0.196x | -993.88% |
| 2020-12-31 | ₩38.70 Billion | ₩849.38 Million | 0.022x | +116.32% |
| 2019-12-31 | ₩9.66 Billion | ₩-1.30 Billion | -0.134x | -64.54% |
| 2018-12-31 | ₩19.60 Billion | ₩-1.60 Billion | -0.082x | +22.37% |
| 2017-12-31 | ₩23.66 Billion | ₩-2.49 Billion | -0.105x | +94.93% |
| 2016-12-31 | ₩1.82 Billion | ₩-3.77 Billion | -2.076x | -523.69% |
| 2015-12-31 | ₩11.20 Billion | ₩-3.73 Billion | -0.333x | -1698.26% |
| 2014-12-31 | ₩7.73 Billion | ₩-143.14 Million | -0.019x | +58.15% |
| 2012-12-31 | ₩17.70 Billion | ₩-783.00 Million | -0.044x | +79.15% |
| 2011-12-31 | ₩11.52 Billion | ₩-2.44 Billion | -0.212x | -- |